NPA

Pharmacies have had over 100,000 patients referred to them by NHS 111 since the CPCS was launched on October 29.

Boris Johnson said the NHS will be the “top priority” for his government after the Conservative's sweeping victory.

NPA, PSNC and the RPS launch the Community Pharmacy Manifesto.

Jay Patel defends wholesalers against suggestions they are to blame for drug shortages.

Independents are unhappy with wholesaler service standards and feel they are sometimes treated unfairly.  

The question of whether the new settlement is a good deal or a bad one is “irrelevant,” the panel said.

Guidance to help LPCS and pharmacy contractors engage with primary care networks is being issued today.

Community pharmacies are more likely to fail a GPhC inspection but also account for all pharmacies rated excellent.

The GPhC said this would improve transparency and “drive improvement in pharmacy services.”

The first details have been released about the Community Pharmacist Consultation Service.

NPA chief pharmacist Leyla Hannbeck has left the NPA after 10 years to become the new chief executive of AIM.

Community pharmacy's unprecedented five-year funding deal has been met with a range of responses.

NPA members must ascertain the contents of any CBD products they intend to sell or risk losing their indemnity.

Nitin Sodha leaves the NPA board following allegations of NHS price fixing at Lexon UK where he is a director. 

LPCs should co-ordinate pharmacists' engagement with primary care networks across England.

Four pharmaceutical companies have provisionally been found to have broken competition law.

The clinical pharmacist role's expansion in PCNs could leave “a big hole” in community pharmacy, Mark Lyonette warns.

Ask Your Pharmacist Week has kicked off, with pharmacies around the country providing information on medicines safety

With 100 days to go before the February 9 deadline for the Falsified Medicines Directive, community pharmacies should not delay in ensuring they are FMD-ready, the National Pharmacy Association has said

The Public Accounts Committee has voiced concerns that the Department of Health and Social Care has no “clear plan” for using new powers to obtain information on the generic medicines market